Biostar Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '17 Sep 30, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Cash & Equivalents	0.36	0.17	0.04	1.69	0.08	1.76
Cash & Short-Term Investments	0.36	0.17	0.04	1.69	0.08	1.76
Cash Growth	-44.65%	345.50%	-97.69%	2004.55%	-95.45%	-89.63%
Accounts Receivable	-	6.74	15.81	26.96	19.6	21.85
Other Receivables	0.46	0.28	0.08	0.12	2.22	4.36
Receivables	0.46	7.03	15.89	36.85	31.64	35.72
Inventory	0.17	0.17	0.23	0.67	0.83	0.85
Prepaid Expenses	-	-	-	0.35	-	-
Other Current Assets	0	0	0	4.07	3.44	3.65
Total Current Assets	1	7.37	16.17	43.63	35.99	41.97
Property, Plant & Equipment	5.85	5.87	6.81	8.48	7.73	6.98
Other Intangible Assets	5.38	5.61	6.88	13.27	17.13	9.14
Long-Term Deferred Tax Assets	2.63	2.52	5.41	7.07	2.79	3.67
Other Long-Term Assets	26.58	21.15	16.1	8.8	3.93	8.72
Total Assets	41.43	42.5	51.36	81.25	67.56	70.48
Accounts Payable	2.69	2.84	4.15	5	4.45	5.73
Accrued Expenses	-	-	0.11	0.43	0.34	0.63
Short-Term Debt	2.43	2.33	2.77	3.09	-	6.34
Other Current Liabilities	0.17	0.46	0.06	0.38	-	-
Total Current Liabilities	5.28	5.62	7.1	8.91	4.79	12.7
Total Liabilities	5.28	5.62	7.1	8.91	4.79	12.7
Common Stock	0	0	0	0	0.01	0.01
Additional Paid-In Capital	31.38	31.38	30.32	30.32	25.75	23.27
Retained Earnings	2.36	4.81	10.51	35.62	30.78	29.97
Comprehensive Income & Other	2.4	0.68	3.43	6.39	6.24	4.53
Total Common Equity	36.15	36.88	44.27	72.34	62.77	57.77
Shareholders' Equity	36.15	36.88	44.27	72.34	62.77	57.77
Total Liabilities & Equity	41.43	42.5	51.36	81.25	67.56	70.48
Total Debt	2.43	2.33	2.77	3.09	-	6.34
Net Cash (Debt)	-2.06	-2.15	-2.73	-1.41	0.08	-4.58
Net Cash Per Share	-0.79	-0.94	-1.24	-0.68	0.05	-3.35
Filing Date Shares Outstanding	2.64	2.64	2.21	2.21	1.81	1.43
Total Common Shares Outstanding	2.64	2.64	2.21	2.21	1.81	1.43
Working Capital	-4.28	1.74	9.07	34.72	31.19	29.27
Book Value Per Share	13.71	13.98	20.02	32.72	34.66	40.47
Tangible Book Value	30.77	31.27	37.39	59.07	45.64	48.64
Tangible Book Value Per Share	11.67	11.86	16.91	26.72	25.20	34.07
Buildings	7.84	7.46	8.07	9.55	6.68	5.51
Machinery	1.31	1.25	1.35	1.41	1.41	1.36
Construction In Progress	0.47	0.45	0.48	0.52	2.15	2.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.